Clarius Group LLC Has $462,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Clarius Group LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,540 shares of the company’s stock after acquiring an additional 247 shares during the quarter. Clarius Group LLC’s holdings in HCA Healthcare were worth $462,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare in the second quarter valued at approximately $33,000. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $39,000. Canoe Financial LP acquired a new stake in shares of HCA Healthcare during the third quarter worth $41,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare during the third quarter worth about $41,000. Finally, Northwest Investment Counselors LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $44,000. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have weighed in on HCA. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Barclays lowered their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Oppenheimer increased their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. Finally, StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Stock Performance

NYSE HCA opened at $310.60 on Monday. The firm has a market capitalization of $78.68 billion, a P/E ratio of 13.95, a price-to-earnings-growth ratio of 1.03 and a beta of 1.64. The firm’s fifty day moving average price is $316.69 and its two-hundred day moving average price is $353.01. HCA Healthcare, Inc. has a 1 year low of $278.50 and a 1 year high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a $0.66 dividend. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.85%. HCA Healthcare’s dividend payout ratio is 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.